About Sandor Life Sciences Private Limited
Data last updated:
Sandor Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Sandor Speciality Diagnostics Private Limited. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 16 July 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85110TG2004PTC043672. Its GSTIN is 36AAJCS1952P1ZQ (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10.9 Cr and a paid-up capital of ₹3.23 Cr. It was formerly known as Sandor Proteomics Private Limited. It is led by directors including Rajeev Sindhi (Managing Director) and Tirunelveli Padmanabhan Devarajan.
Its last annual general meeting (AGM) was held on 03 July 2023, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2021, the company reported a revenue of ₹6.02 Cr, a decline of 33% compared to the previous year. For the same year it recorded a net loss of ₹11.36 Cr (net margin -188.6%) and EBITDA of ₹6.01 Cr (EBITDA margin 99.8%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 11% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
The company is associated with 3 brands: Sandor Medicaids, Quintype Systems and Sandor Lifesciences. As per MCA filings, the company has open charges of ₹74.31 Cr and satisfied charges of ₹19.51 Cr on record. Court records list 8 cases involving the company, including 8 filed against it. The company has 9 deals on record (4 secondary share transfers, 3 funding rounds, 1 debt financing), with disclosed funding of ₹38.22 Cr; the latest was in July 2020. Its 10 peer companies in the Biotechnology industry (Biotechnology) are compared by revenue, 5 larger and 5 smaller; the largest is Biolivz Research Center Private Limited with revenue of ₹6.58 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sandor.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address8 – 2 – 293/82/Jiii/471/A Ground Floor, Jubilee Hills, Hyderabad, Telangana, India – 500033
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sandor Life Sciences Private Limited
The main business activities of Sandor Life Sciences are professional, scientific and technical and support service to organizations. In detail, this covers scientific research and development and other support services to organizations. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sandor Life Sciences Private Limited FY 2021 filings available
Sandor Life Sciences Private Limited reported revenue of ₹6.02 Cr (down 33% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Sandor Life Sciences Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 33% fall in the latest year. EBITDA rose 137% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sandor Life Sciences Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.01 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹11.36 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sandor Life Sciences Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 99.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -188.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sandor Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Sandor Life Sciences Private Limited
Sandor Life Sciences Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biolivz Research Center Private Limited | ₹6.58 Cr (FY 2025) | •••• | •••• | 625.0% | •••• | Telangana, India |
| Mannika Biotech Private Limited | ₹6.38 Cr (FY 2024) | •••• | •••• | 182.0% | •••• | Delhi, India |
| Dscign Biosys Private Limited | ₹6.36 Cr (FY 2024) | •••• | •••• | -62.0% | •••• | Bengaluru, Karnataka, India |
| Privi Biotechnologies Private Limited | ₹6.15 Cr (FY 2025) | •••• | •••• | -32.0% | •••• | Navi Mumbai, Maharashtra, India |
| Genesys Biologics Private Limited | ₹6.08 Cr (FY 2024) | •••• | •••• | 87.0% | •••• | Hyderabad, Telangana, India |
| Sandor Life Sciences Private Limited this company | ₹6.02 Cr (FY 2021) | •••• | •••• | -33.0% | •••• | Hyderabad, Telangana, India |
| Callus Biotech Private Limited | ₹6.01 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Kolhapur, Maharashtra, India |
| Vastu Vihar Biotech Private Limited | ₹5.96 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Patna, Bihar, India |
| Hitarth Biotech Private Limited | ₹5.93 Cr (FY 2020) | •••• | •••• | -70.0% | •••• | Bangalore, Karnataka, India |
| Pushpa Biotech Private Limited | ₹5.85 Cr (FY 2025) | •••• | •••• | 172.0% | •••• | Jaipur, Rajasthan, India |
| Aristogene Biosciences Private Limited | ₹5.85 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Sandor Life Sciences by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sandor Life Sciences Private Limited
Sandor Life Sciences Private Limited is audited by HARINARAYAN LOYA & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| HARINARAYAN LOYA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Sandor Life Sciences Private Limited
Sandor Life Sciences has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tirunelveli Padmanabhan Devarajan Also directs: Malladi Drugs and Pharmaceuticals Limited, Indilyfe Sponsor LLP, Aizant Drug Research Solutions Private Limited and 3 more | Director | 08 Jan 2016 | 10 Years 9 Months | Current |
| Subramanian Vishar Vasudevan | Director | 11 Jul 2020 | 6 Years 2 Months | Current |
| Rajeev Sindhi Also directs: Sandor Animal Biogenics Private Limited, Sandor Tescon Aqua Private Limited, Sandor Medicaids Private Limited and 3 more | Managing Director | 16 Jul 2004 | 22 Years 2 Months | Current |
| Gunjan Sindhi Also directs: Sandor Animal Biogenics Private Limited, Sandor Speciality Diagnostics Private Limited, Plexision India Private Limited and 5 more | Director | 16 Dec 2015 | 10 Years 9 Months | Current |
Ownership and Shareholding of Sandor Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sandor Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2023 | State Bank of India | ₹3.15 Cr | Open |
| 20 Aug 2021 | Others | ₹1.86 Cr | Open |
| 30 Oct 2019 | Tata Capital Financial Services Limited | ₹1.5 Cr | Open |
| 16 Sep 2019 | State Bank of India | ₹32 Cr | Open |
| 08 Jan 2016 | Others | ₹35 Cr | Open |
Total charge records: 10 View all charges
Deals & Funding of Sandor Life Sciences Private Limited
Sandor Life Sciences Private Limited has 9 deals on record (4 secondary share transfers, 3 funding rounds, 1 debt financing), with disclosed funding of ₹38.22 Cr; the latest was in July 2020.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2020 | Acquisition | ₹7.5 Cr | Buyer: InvAscent |
| Aug 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jan 2016 | Debt financing | ₹35 Cr | Investors: InvAscent |
| Dec 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Sp Biosciences Private Limited, an individual |
Full deal history
All 9 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Sandor Life Sciences Private Limited
Sandor Life Sciences Private Limited has 8 court cases on record: 8 filed against it. All cases are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 8 | 0 |
Cases on record (4 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Execution petition | Filed against the company by NGB Diagnostics Private Limited | Disposed |
| District court, Shahdara, Delhi | Execution petition | Filed against the company by NGB Diagnostics Private Limited | Disposed |
| District court, Shahdara, Delhi | Interim or miscellaneous application | Filed against the company by NGB Diagnostics Private Limited | Disposed |
| District court, Shahdara, Delhi | Commercial suit | Filed against the company by NGB Diagnostics Private Limited | Disposed |
Full case history
All 8 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Sandor Life Sciences Private Limited
Sandor Life Sciences operates multiple associated brands including Sandor Medicaids, Quintype Systems, and Sandor Lifesciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of medical equipment, devices, and drugs distribution services | sandor.co.in | |
| Provider of a digital experience platform with publishing CMS and engagement tools | quintype.com | |
| Genomics services including genetic testing and research are offered. | sandorlifesciences.co.in |
Employees and EPFO Compliance at Sandor Life Sciences Private Limited
Sandor Life Sciences Private Limited has a workforce of 1 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Sandor Life Sciences Private Limited
Sandor Life Sciences has 1 associated company. This group structure data is as of FY 2020. The table lists each entity with its relationship and holding.
CIN History of Sandor Life Sciences Private Limited
Sandor Life Sciences has one previous CIN (Corporate Identification Number): U85110AP2004PTC043672. The current CIN is U85110TG2004PTC043672, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110TG2004PTC043672 | Current |
| U85110AP2004PTC043672 | Previous |
News related to Sandor Life Sciences Private Limited
Recent Activity on Sandor Life Sciences Private Limited
Sandor Life Sciences Private Limited has 12 board changes on record since 2004: 4 appointments and 8 cessations. The latest: Subramanian Vishar Vasudevan ceased to be Additional Director on 13 Jul 2020.
20 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Sandor Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sandor Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sandor Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sandor Life Sciences Private Limited
Sandor Life Sciences has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCS1952P1ZQ | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sandor Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandor Life Sciences Private Limited
Sandor Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 16 July 2004 (22+ years old) and is registered under CIN U85110TG2004PTC043672.
Sandor Life Sciences reported revenue of ₹6.02 Cr for FY 2021 (down 33% YoY).
Sandor Life Sciences has 4 current directors:
- Rajeev Sindhi - Managing Director
- Tirunelveli Padmanabhan Devarajan - Director
- Subramanian Vishar Vasudevan - Director
- Gunjan Sindhi - Director
Sandor Life Sciences reported a net loss of ₹11.36 Cr (net margin -188.6%) and EBITDA of ₹6.01 Cr (EBITDA margin 99.8%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sandor Life Sciences is -17% over three years and -11% over five years. In the latest year (FY 2021) revenue fell 33%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sandor Life Sciences is 36AAJCS1952P1ZQ, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Sandor Life Sciences is U85110TG2004PTC043672. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sandor Life Sciences has 8 court cases on record: 8 filed against it.
Sandor Life Sciences was incorporated on 16 July 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sandor Life Sciences has 9 deals on record (4 secondary share transfers, 3 funding rounds, 1 debt financing), with disclosed funding of ₹38.22 Cr; the latest was in July 2020.
The peers of Sandor Life Sciences by revenue are Biolivz Research Center Private Limited, Mannika Biotech Private Limited, Dscign Biosys Private Limited, Privi Biotechnologies Private Limited, Genesys Biologics Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).